Brief: Ekso Bionics Reports Q4 And Year End 2020 Results
25/02/2021 22:25
Feb 25 (Reuters) - Ekso Bionics Holdings Inc EKSO.O :
* EKSO BIONICS REPORTS FOURTH QUARTER AND YEAR END 2020
RESULTS
* Q4 REVENUE $2.3 MILLION VERSUS $3.7 MILLION
* Q4 LOSS PER SHARE $0.48
* CASH AT DECEMBER 31, 2020 WAS $12.9 MILLION, COMPARED TO
$10.9
MILLION AT DECEMBER 31, 2019
Source text for Eikon: ID:nGNX6W50xq
Further company coverage: EKSO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chronoscale
See all newsBrief: Chronoscale To Divest Ekso Bionics And Focus On Cloud Business
Brief: Applied Digital Completes Separation Of Cloud Business, Establishing Chronoscale As Independent Public Company
Brief: Ekso Bionics Holdings On Feb 15, Enters Agreement With Apld Intermediate
Applied Digital jumps after Q2 revenue beats on AI data center demand
Applied Digital beats quarterly revenue estimates on AI data center demand, shares jump